Related Experiment Video
Updated: Jul 11, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells
Biju Parekkadan1, Daan van Poll, Zaki Megeed
1Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Harvard Medical School and the Shriners Hospitals for Children, 51 Blossom Street, Boston, MA 02114, USA.
Abstract:
Bone marrow-derived mesenchymal stem cells (MSCs) have been reported to prevent the development of liver fibrosis in a number of pre-clinical studies. Marked changes in liver histopathology and serological markers of liver function have been observed without a clear understanding of the therapeutic mechanism by which stem cells act. We sought to determine if MSCs could modulate the activity of resident liver cells, specifically hepatic stellate cells (SCs) by paracrine mechanisms using indirect cocultures. Indirect coculture of MSCs and activated SCs led to a significant decrease in collagen deposition and proliferation, while inducing apoptosis of activated SCs. The molecular mechanisms underlying the modulation of SC activity by MSCs were examined. IL-6 secretion from activated SCs induced IL-10 secretion from MSCs, suggesting a dynamic response of MSCs to the SCs in the microenvironment. Blockade of MSC-derived IL-10 and TNF-alpha abolished the inhibitory effects of MSCs on SC proliferation and collagen synthesis. In addition, release of HGF by MSCs was responsible for the marked induction of apoptosis in SCs as determined by antibody-neutralization studies. These findings demonstrate that MSCs can modulate the function of activated SCs via paracrine mechanisms provide a plausible explanation for the protective role of MSCs in liver inflammation and fibrosis, which may also be relevant to other models of tissue fibrosis.
Insights
Mesenchymal stem cells (MSCs) inhibit liver fibrosis by modulating hepatic stellate cells (SCs) through paracrine signaling. MSCs reduce SC proliferation and collagen production while inducing SC apoptosis, clarifying their therapeutic mechanism.
Area of Science:
- Stem cell biology
- Hepatology
- Immunology
Background:
- Mesenchymal stem cells (MSCs) show promise in preclinical liver fibrosis models.
- The precise therapeutic mechanisms of MSCs in liver fibrosis remain unclear.
Purpose of the Study:
- To investigate if MSCs modulate hepatic stellate cell (SC) activity via paracrine mechanisms.
- To elucidate the molecular pathways involved in MSC-mediated SC modulation.
Main Methods:
- Indirect co-culture of MSCs and activated SCs.
- Analysis of collagen deposition, SC proliferation, and apoptosis.
- Investigation of cytokine secretion (IL-6, IL-10, TNF-alpha) and growth factor (HGF) involvement.
- Antibody-neutralization studies to block specific molecular interactions.
Main Results:
- Indirect co-culture significantly decreased collagen deposition and SC proliferation while increasing SC apoptosis.
- MSCs secreted IL-10 in response to SC-derived IL-6.
- Blocking MSC-derived IL-10 and TNF-alpha abolished the inhibitory effects on SC proliferation and collagen synthesis.
- MSC-derived HGF was responsible for inducing SC apoptosis.
Conclusions:
- MSCs modulate activated SC function through paracrine mechanisms, including IL-10, TNF-alpha, and HGF.
- These findings provide a mechanistic explanation for the protective role of MSCs in liver fibrosis.
- The identified mechanisms may be relevant to other fibrotic conditions.
Related Concept Videos
Mesenchymal Stem Cells
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Stem Cell Niche
Cirrhosis II: Pathophysiology

